The company's plants have implemented a quality control system in compliance with the international GMP standards.
-
GMP
Good Manufacturing Practice
-
3
modern pharmaceutical plants
-
ISO 9001
international quality standard
Avexima has brought dozens of pharmaceutical products on the market. Their efficacy and affordability have earned high appraisal from both healthcare professionals and consumers, making them a product of choice.
We make significant investments in equipment modernization and the expansion of production capabilities, taking into account the current trends and developments in the pharmaceutical market.
Production
capacities
MANUFACTURING
CAPABILITIES
In light of the pressing need to strengthen Russia's pharmaceutical security, Avexima has become the key initiator and investor in an investment project to create a major pharmaceutical cluster in the Yesipovo Industrial Park, Moscow Region. The project to establish a modern pharmaceutical production and logistics complex (FPLC) is a tangible implementation of the company's development strategy aligned with the state program Pharma 2030.
INVESTMENT PROJECT
YESIPOVO FPLC
Investment project in the Yesipovo Industrial Park in the Solnechnogorsk District of the Moscow Region.
LEARN MORE
The Yesipovo FPLC will become an advanced center for scientific research and the production of modern drugs. Furthermore, in partnership with the pharmaceutical distributor FC Grand Capital, a modern logistics center for drug distribution will be built.